Published in
Elsevier, Bulletin du Cancer, 3(109), p. 250-252, 2022
DOI: 10.1016/j.bulcan.2022.01.002
Links
Tools
Nouvelles AMM : ripretinib dans le traitement des GIST avancées à partir de la quatrième ligne
Journal article published in 2022 by
Joséphine Lemaître,
Sarah Watson 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 